1. Home
  2. RLMD vs SRG Comparison

RLMD vs SRG Comparison

Compare RLMD & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • SRG
  • Stock Information
  • Founded
  • RLMD 2004
  • SRG 2014
  • Country
  • RLMD United States
  • SRG United States
  • Employees
  • RLMD N/A
  • SRG N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • SRG Real Estate Investment Trusts
  • Sector
  • RLMD Health Care
  • SRG Real Estate
  • Exchange
  • RLMD Nasdaq
  • SRG Nasdaq
  • Market Cap
  • RLMD 289.7M
  • SRG 236.0M
  • IPO Year
  • RLMD N/A
  • SRG 2015
  • Fundamental
  • Price
  • RLMD $4.22
  • SRG $3.46
  • Analyst Decision
  • RLMD Buy
  • SRG
  • Analyst Count
  • RLMD 2
  • SRG 0
  • Target Price
  • RLMD $5.50
  • SRG N/A
  • AVG Volume (30 Days)
  • RLMD 2.1M
  • SRG 151.5K
  • Earning Date
  • RLMD 11-13-2025
  • SRG 11-14-2025
  • Dividend Yield
  • RLMD N/A
  • SRG N/A
  • EPS Growth
  • RLMD N/A
  • SRG N/A
  • EPS
  • RLMD N/A
  • SRG N/A
  • Revenue
  • RLMD N/A
  • SRG $17,406,000.00
  • Revenue This Year
  • RLMD N/A
  • SRG N/A
  • Revenue Next Year
  • RLMD N/A
  • SRG N/A
  • P/E Ratio
  • RLMD N/A
  • SRG N/A
  • Revenue Growth
  • RLMD N/A
  • SRG N/A
  • 52 Week Low
  • RLMD $0.24
  • SRG $2.43
  • 52 Week High
  • RLMD $5.12
  • SRG $4.72
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 72.46
  • SRG 29.95
  • Support Level
  • RLMD $3.81
  • SRG $3.38
  • Resistance Level
  • RLMD $5.12
  • SRG $4.23
  • Average True Range (ATR)
  • RLMD 0.55
  • SRG 0.14
  • MACD
  • RLMD 0.05
  • SRG -0.07
  • Stochastic Oscillator
  • RLMD 64.44
  • SRG 10.59

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About SRG Seritage Growth Properties

Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.

Share on Social Networks: